Study characteristics |
Methods |
Randomized, controlled |
Participants |
On‐pump CABG only |
Interventions |
Sotalol vs. Control |
Outcomes |
SVA lasting at least 1 minute with a heart rate of greater than 120 bpm; LOS |
Follow‐Up |
Hospital discharge; 1‐3 month postoperative follow‐up |
Concurrent Antiarrhythmic Medications |
None |
Notes |
|
Risk of bias |
Bias |
Authors' judgement |
Support for judgement |
Random sequence generation (selection bias) |
Unclear risk |
No randomization method mentioned |
Allocation concealment (selection bias) |
Unclear risk |
Insufficient information |
Blinding of participants and personnel (performance bias)
All outcomes |
High risk |
Not placebo controlled |
Blinding of outcome assessment (detection bias)
All outcomes |
Unclear risk |
Insufficient information |
Incomplete outcome data (attrition bias)
All outcomes |
High risk |
Event rates based on post‐randomization drop‐outs, but baseline characteristics not adjusted for |
Selective reporting (reporting bias) |
High risk |
Adverse outcomes such as bradycardia not reported as risk factor, although high dropout rate due to complications |
Intention‐to‐treat analysis |
High risk |
No |